Cardeas Pharma's Series B Round

Cardeas Pharma raised a round of funding on May 23, 2013.

Cardeas is a privately held biopharmaceutical company dedicated to the development and commercialization of inhaled antibiotics to treat serious, hospital-acquired respiratory infections with highly a…

Articles about Cardeas Pharma's Series B Round: